The Pharma Letter - 2024/12/16查看原文

Relation Therapeutics

Relation’s 'Lab-in-the-Loop' platform combines human genetics, single-cell multi-omics directly from human tissue, functional assays, and machine learning to discover novel disease interventions. The company has programmes across metabolic and immune diseases. As of Q4 2024, the company has raised over $80 million from leading investors.
立即投票
我只有一個字送給大家,多!
我大概只有一句話,空!
我還能說什麼,歐印!
探索更多相關標籤貼文: